Trial Details
COMPLETEDBasic Information
| Clinical ID | c1017 |
|---|---|
| Identifier | NCT02093663 |
| Trial Title | Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: MMX Mesalamine/Mesalazine (Low Dose)|DRUG: MMX Mesalamine/Mesalazine (High Dose) |
Participant Information
| Sponsor | Shire |
|---|---|
| City | Baltimore |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-12-12 |
|---|---|
| Primary Completion Date | 2018-11-28 |
| Completion Date | 2018-11-28 |